Home › Research › Risk factors
Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia
Xin Ma, Xin-Meng Wang, Guozhang Tang, Yi Wang, Yi Wang, Xue‑Chun Liu, Shuai-Deng Wang, Peng Peng et al.. Amino Acids, 2025-01-18
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Metabolomics provide a promising tool for understanding dementia pathogenesis and identifying novel biomarkers. This study aimed to identify amino acid biomarkers for Alzheimer's Disease (AD) and Vascular Dementia (VD). By amino acid metabolomics, the concentrations of amino acids were determined in the serum of AD and VD patients as well as age-matched healthy controls. Several differences in the concentration of amino acids were observed in AD patients compared to both healthy controls and VD patients. However, no significant distinction was found between healthy controls and VD patients. Considering comorbidities, cystine levels were higher in AD than in VD among non-diabetic patients, but not in those with diabetes. Notably, creatine, spermidine, cystine, and tyrosine demonstrated favorable results in decision curve analyses and good discriminative performances, suggesting their potential for clinical application. These fundings give novel perspectives of serum amino acids for predicting metabolic pathways in AD and VD pathogenesis.
What this study adds
Evidence grade: Low
This study found differences in amino acid levels in the blood of people with Alzheimer's disease compared to healthy controls and those with vascular dementia, but no significant difference between healthy controls and vascular dementia patients. Certain amino acids showed promise as potential markers, but more research is needed before they could be used clinically.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ma, X., Wang, X.-M., Tang, G., Wang, Y., Liu, X., Wang, S.-D., et al. (2025). Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia. Amino Acids. https://doi.org/10.1007/s00726-024-03442-1
Vancouver
Ma X, Wang X.-M, Tang G, Wang Y, Liu X, Wang S.-D, et al. Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia. Amino Acids. 2025. doi:10.1007/s00726-024-03442-1. PMID: 39825947.
BibTeX
@article{ma2025-39825947,
author = {Ma, Xin and Wang, Xin-Meng and Tang, Guozhang and Wang, Yi and Liu, Xue‑Chun and Wang, Shuai-Deng and Peng, Peng and others},
title = {{Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia}},
journal = {Amino Acids},
year = {2025},
doi = {10.1007/s00726-024-03442-1},
pmid = {39825947},
url = {https://doi.org/10.1007/s00726-024-03442-1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Several differences in the concentration of amino acids were observed in AD patients compared to both healthy controls and VD patients.
- However, no significant distinction was found between healthy controls and VD patients.
- Notably, creatine, spermidine, cystine, and tyrosine demonstrated favorable results in decision curve analyses and good discriminative performances, suggesting their potential for clinical application.
Why it matters
This study found differences in amino acid levels in the blood of people with Alzheimer's disease compared to healthy controls and those with vascular dementia, but no significant difference between healthy controls and vascular dementia patients. Certain amino acids showed promise as potential markers, but more research is needed before they could be used clinically.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Amino Acids) |
| Journal's citation record | 2 / 4 | Amino Acids: journal h-index 166 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 14 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 8.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 14 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Jiang‐Ning Zhou: h-index 57 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Anhui Medical University: institution h-index 405 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39825947) |
| Free to read | 2 / 2 | Free to read |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 17.
Related studies in Risk factors from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.